Document Type : Original Article
Authors
- Mojtaba Farjam 1
- Azizalah Dehghan 2
- Mostafa Bijani 3
- Soha Salimi 4
- Ehssan Bahramali 2
- Abdolhakim Alkamel 2
1 Non Communicable Diseases Research Center (NCDRC), Fasa University of Medical Sciences, Fasa, Iran .
2 Non Communicable Diseases Research Center (NCDRC), Fasa University of Medical Sciences, Fasa, Iran
3 Assistant Professor, Department of Medical Surgical Nursing, Fasa University of Medical Sciences, Fasa, Iran.
4 Student research committee, Fasa University of Medical Sciences. Fasa,Iran
Abstract
Background: One of the major risk factors in cardiovascular diseases is Opiate abuse. Accordingly, the present study aims to investigate the complications and consequences of myocardial infarction between Abusers and Non-abusers of Opiate in the south of Iran
Methods: The present study is a cross-sectional work of research. 1800 myocardial infarction (MI) patients at Fasa Registry on Acute Myocardial Infarction (FaRMI) were selected for study. Data were collected from 2015 to 2020. The collected data were analyzed in SPSS v. 22 using the statistical tests of independent t-test and chi-square. Significance level was set at p<0.05.
Results: Out of the 1800 patients, 593 (32.9%) were female and 1207 (67.1%) were male. The rate of Opiate abuse in the study population was found to be 25.6. The results showed a significant relationship between the Opiate patients’ average age and gender on the one hand and Opiate abuse on the other (p<0.001). Also, Opiate abuse was found to significantly correlate with hypertension, diabetes, and hyperlipidemia as risk factors in AMI (p<0.001).
Conclusion: Given the prevalence of Opiate abuse and its role in cardiovascular diseases, especially AMI , in the present study, it is recommended that the senior administrators in the healthcare system take effective measures to raise public awareness about the potential harms of Opiate abuse.
Keywords
Introduction
Among the major causes of death all over the world, cardiovascular diseases have posed healthcare systems with a variety of challenges, including an increase in the rate of hospitalization and high medical expenses [1]. According to WHO, 50% of the mortality rate in developed countries and 30% of the mortality rate in developing countries are due to coronary artery diseases (CAD) [2]. The American Heart Association reports that 35% of the deaths in the world are caused by cardiovascular diseases [3]. The results of studies in Iran show that the first and most common cause of death among patients is cardiovascular diseases, especially cardiac arrest—over 40% of the mortality rate in Iran is owing to cardiac arrest and related consequences [4-5]. A variety of factors can lead to cardiovascular diseases, one of the most significant of which is drug abuse. According to WHO, drug abuse is a major contributory and aggravating factor in most diseases, especially chronic, non-infectious diseases, including cardiovascular diseases, respiratory diseases, cancer, and stroke [6]. The results of a review study conducted by Ziaee et al. (2019) show that opium abuse can, in the long-term, lead to changes in plasma fibrinogen levels, coagulation, atherosclerosis, and cause or aggravate coronary artery diseases (CAD), hypertension, cardiac arrest, and stroke [7]. Although the abuse of opium has significantly decreased in many societies, developing countries, including Iran, have seen a sharp rise in drug abuse [8]. The results of a study in Iran show that 38.3% of patients hospitalized due to cardiac arrest or a coronary artery disease are addicted to opium [9]. In addition, according to the study of Khalili et al. (2021), 46.19% of men and 4.27% of women in Iran abuse opiate drugs at least once every six months [10].
Few studies have comprehensively addressed the relationship between Opiate abuse and the complications and consequences of MI in the cultural context of Iran. Accordingly, the present study was conducted to investigating the complications and consequences of MI between Abusers and Non-abusers of Opiate in the south of Iran from 2015 to 2020.
Methods
The present study is a case-control work of research. Selected through complete enumeration, 1800 cardiac arrest patients from FaRMI were included in the study. FaRMI is the first population-based registry for AMI in Iran targeted to provide meticulous description of patients’ characteristics, explore their management patterns, discover the degree of adherence to the practice guidelines, and investigate the determinants of poor in-hospital and later outcomes. FaRMI is credited with the first approved national MI registry system in the ministry of health (MOH) center for registries. For the first time in Iran, it will enable documentation of the long-term (5 years) outcomes of patients presenting with AMI in 2020. [11].
Data were collected from 2015 to 2020. The subjects were selected according to consensus sampling technique. Accordingly, a total number of 1800 participants aged 30 years old or above were recognized as eligible and then invited to participate in this study . The exclusion criteria were inability to answer the items on the questionnaire due to emotional issues, Alzheimer’s disease, or psychological disorders. In the present study, the patients were divided into three groups: Opiate addicts, non-addicts, and former Opiate addicts.
To collect data, the researchers used a questionnaire based on FaRMI. The questionnaire included items on demographic characteristics, degree and method of Opiate abuse, smoking cigarettes and hookahs, hypertension, hyperlipidemia, and diabetes. The researchers also recorded the MI patients’ length of stay, its symptoms, type of cardiac arrhythmia, type of treatment, extent and location of MI, and rate of hospital mortality. The collected data were analyzed in SPSS v. 22 using the statistical tests of independent t-test and chi-square. P-values of smaller than 0.05were considered to be statistically significant.
Ethical Considerations
All the participants gave written informed consent to participate in the study. The present study was conducted in terms of the principles of the revised Declaration of Helsinki, which is a statement of ethical principles that directs physicians and other participants in medical research involving human subjects. The participants were assured about their anonymity and the confidentiality of their information. Moreover, the study was approved by the Institutional Research Ethics Committee of Fasa University of Medical Sciences, Fasa, Iran (code: IR.FUMS.REC.1398.063).
Results
Out of the 1800 patients, 593 (32.9%) were female and 1207 (67.1%) were male. The patients’ average age was 63.3±13.36 years. The results showed a significant relationship between the participants’ average age, gender, and place of residence on the one hand and Opiate abuse on the other (p<0.001). Opiate was found to be the most commonly used drug in the study population (23.9%) (Table1).
Moreover, the results showed that there was a significant relationship between smoking cigarettes and hookahs on the one hand and drug abuse on the other (Table 2).
Likewise, the results showed that there was a significant relationship between hypertension, diabetes, and hyperlipidemia as cardiac arrest risk factors on the one hand and drug abuse on the other (p<0.001) (Table 3).
The most common symptoms of MI were found to be angina and dyspnea. Also, the results showed a significant relationship between the patients’ history of drug abuse and their back pains and cold sweats (Table 4).
Based on the findings of the study, there was not a significant relationship between the location of cardiac arrest, type of arrest and administered treatment, mortality rate during hospital stay, mortality rate in one year. The other factors are shown in Table 5.
Discussion
Identifying and examining the risk factors in cardiovascular diseases, including cardiac arrest, play a significant part in preventing and taking effective measures toward eliminating these factors (12]. In the current study, the rate of Opiate abuse was found to be 25.6%, with opium being the most commonly abused drug. Also, 62% of the subjects smoked cigarettes in addition to abusing Opiate. Considering the prevalence of smoking and opium abuse as major risk factors in cardiovascular diseases, cardiac arrest, stroke, and cancer, healthcare administrators and policy-makers are required to devise plans to prevent and eliminate these risk factors. According to the American Heart Association, Opiate abuse and smoking are major modifiable risk factors in cardiovascular diseases and healthcare policy-makers should take measures to control addiction to smoking and opium and develop comprehensive plans to raise public health awareness and promote self-care behaviors [13].
The findings of this study show that there is a significant relationship between MI on the one hand and age, gender, and opium abuse on the other, which is consistent with the results of the study of Harati et al [14]. The results of the present study also show that there is a significant relationship between Opiate abuse on the one hand and hypertension, cardiac arrest, and diabetes on the other. Similarly, Nakhaee et al. (2020) and Adib et al. (2020) report that Opiate abuse directly correlates with hypertension and cardiac arrest and, thus, opium abusers are more prone to cardiac arrest and hypertension. They also report that the relationship between Opiate abuse and mortality rate during hospital stay is not significant, which is in tune with the findings of the present study [15-16]. However, according to the studies of Masoudkabir et al. (2020), Najafi et al. (2016), and Rostamzadeh et al. (2016), there is a significant relationship between Opiate abuse and the mortality rate of hospitalized patients with a cardiac disease, which is not consistent with the findings of the present study. This discrepancy can be attributed to differences in sample size and the fact that the above-mentioned works are cohort studies. Also, differences in cultural contexts and economic and social conditions can explain the discrepancy [17-19]. The study of Moezi Bady et al. (2020) shows that diabetic patients with a history of cardiac arrest who are addicted to opium are more likely to be re-hospitalized and die than patients who do not abuse Opiate [20].
The results of the present study show that there is not a significant relationship between Opiate abuse and type and location of cardiac arrest. This finding is consistent with the results of the studies of Nadimi et al. (2016) and Roohafz et al.(2013) [21-22]. Furthermore, in the current study, the most common treatment for cardiac arrest for both abusers and non-abusers of opium was found to be Primary PTCA which is a modern method that replaced coronary artery bypass surgery for treating many patients with blocked coronary arteries. Research show that over 85% of patients with a cardiovascular disease can be treated by angioplasty. This method is a safer, less invasive, and more economical treatment than coronary artery bypass surgery. It has also been found to result in shorter hospital stays for patients [23-24].
Limitations
Since drug abuse is influenced by cultural, social, and economic factors, the findings of the present study may not be transferrable to other regions of Iran or other countries. Therefore, there is a need for more research, especially cohort studies, with larger sample sizes. Our study limitations included inaccurate amount of causes, the route of abuse, the followed observational design, the potential for residual confounding, and self –reported data.
Conclusion
Given the increase in Opiate abuse and smoking which are significant risk factors in cardiovascular diseases, especially cardiac arrest, it is vital for senior healthcare administrators to take effective measures to raise public awareness about the potential harms of Opiate abuse and smoking and develop executive plans to control and eliminate these risk factors. The promotion of self-care behaviors can also play a major part in improving public health and minimizing health risk factors.
Acknowledgements
The study was approved by the Institutional Research Ethics Committee of Fasa University of Medical Sciences, Fasa, Iran [code: IR.FUMS.REC.1398.063). The authors appreciate Hamadan University of Medical Sciences for financially supporting this research
Conflict of interest:
None to be declared.
Funding and support:
None
- Angaw DA, Ali R, Tadele F, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord .2021;21[37):1-9. https://doi.org/10.1186/s12872-020-01828-z
- Timmis A, Townsend N, Gale C, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019. European Heart Journal.2020;41[1): 12–85. https://doi.org/10.1093/eurheartj/ehz859
- Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology.2020;76[25): 2982-3021 https://doi.org/10.1016/j.jacc.2020.11.010
- Fakhri M, Sarokhani D, Ghiasi B, Dehkordi HA. Prevalence of hypertension in cardiovascular disease in Iran: Systematic review and meta‑ Int J Prev Med 2020;11[56):1-10. 10.4103/ijpvm.IJPVM_351_18
- Sarrafzadegan N, Mohammadifard N. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Arch Iran Med.2019;22[4):204-210.
- Roayaei P, Aminorroaya A, Vasheghani-Farahani A, Oraii A, Sadeghian S, Poorhosseini H.et all. Opium and cardiovascular health: A devil or an angel? Indian Heart Journal2020;72[6): 482-490. https://doi.org/10.1016/j.ihj.2020.10.003
- Ziaee M, Hajihzadeh R, Khorrami A, Sepehrvand N, Momtaz S, Ghaffarhi S. Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article.IranJPublicHealth.2019;48[12):2154-2164 https://doi.org/10.18502/ijph.v48i12.3546
- Rezaei N, Alinia P, Aghabiklooei A, Izadi Sh. Blood Lead Level in Opium Abuse; Which Is More Dangerous? Opium Smoking or Opium Ingestion? Asia Pac J Med Toxicol 2019;8[4):124-9
- AdibA, Masoompour SM, Molavi Vardanjani H, Gondomkar A, Poustchi H, Salehi A, et al. Smoking water-pipe, opium use and prevalence of heart disease: a cross-sectional analysis of baseline data from the Pars Cohort Study, Southern Iran. Arch Iran Med. 2020;23[5):289–295. doi: 10.34172/aim.2020.17.
- Khalili P, Ayoobi F, Mohamadi M, Jamalizadeh A, LaVecchia C, Nadimi AE. Effect of opium consumption on cardiovascular diseases – a cross- sectional study based on data of Rafsanjan cohort study. BMC CardiovascDisord.2021:21[2):1-11. https://doi.org/10.1186/s12872-020-01788-4
- Bahramali E, Askari A, Zakeri H, Farjam M, Dehghan A, Zendehdel K Fasa Registryon AcuteMyocardial Infarction[FaRMI): FeasibilityStudyand Pilot PhaseResults. PLoSONE .2016;11[12):e0167579. doi:10.1371/journal.pone.0167579
- Santos P. The Role of Cardiovascular Risk Assessment in Preventive Medicine: A Perspective from Portugal Primary Health- Care Cardiovascular Risk Assessment. Journal of Environmental and Public Health.2020:1-7.
https://doi.org/10.1155/2020/1639634
- Dewan KC, Dewan KS, Idrees JJ, Navale SM, Rosinski BF, Svensson LG, et al. Trends and Outcomes of Cardiovascular Surgery in Patients with Opioid Use Disorders. JAMA Surg. 2019 Mar 1;154[3):232-240. doi: 10.1001/jamasurg.2018.4608.
- Harati H, Shamsi A, Moghadam MF, Zadeh FSS, Ghazi A. The Mortality Rateof Myocardial Infraction Patients With and Without Opium Dependen. Int JHigh Risk Behav Addict. 2015;4[3):e22576.
- Nakhaee S, Ghasemi S, Karimzadeh K, Zamani N, Alinejad-Mofrad S, Mehrpour O. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Subst Abuse Treat Prev Policy. 2020 Apr 17;15[1):30. doi: 10.1186/s13011-020-00272-8. PMID: 32303254;
- Adib A, Masoompour SM, Molavi Vardanjani H, Gondomkar A, Poustchi H, Salehi A, et al. Smoking Water-Pipe, Opium Use and Prevalence of Heart Disease: A Cross-sectional Analysis of Baseline Data from the Pars Cohort Study, Southern Iran. Arch Iran Med. May 2020;23[5):289-295. doi: 10.34172/aim.2020.17
- Masoudkabir F, Yavari N, Pashang M, Sadeghian S, Jalali A, Poorhosseini H, et al. Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularization. European Journal of Preventive Cardiology.2020;27[18):1-8
https://doi.org/10.1177/2047487320932010
- Najafi M, Jahangiry L, Mortazavi SH, Jalali A, Karimi A, Bozorgi A. Outcomes and long-term survival of coronary artery surgery: the controversial role of opium as risk marker. World J Cardiol. 2016;8[11):676.
- Rostamzadeh A, Khademvatani K. Comparison of myocardial infarction outcome in opium dependent and non-dependent patients. J Urmia Univ Med Sci. 2016;27[3):208–14.
- Moezi Bady SA, Soltani M, Kazemi T, Khosravi Bizhaem S, Hanafi Bojd N, Partovi N, et al. Surveying the Effect of Opioid Abuse on the Extent of Coronary Artery Diseases in Diabetic Patients. Journal of Addiction.2020:1-5. doi: 10.1155/2020/8619805.
- Nadimi AE, Amiri FP, Fathollahi MS, Hassanshahi G, Ahmadi Z, Sayadi AR. Opium addiction as an independent risk factor for coronary microvascular dysfunction: a case–control study of 250 consecutive patients with slow–flow angina. Int J Cardiol. 2016;219:301-7. doi: 10.1016/j.ijcard.2016.06.034.
- Roohafza H, Talaei M, Sadeghi M, Haghani P, Shokouh P, Sarrafzadegan N. Opium decreases the age at myocardial infarction and sudden cardiac death: A long- and short-term outcome evaluation. Arch Iran Med. 2013; 16[3): 154 – 160.
- Baumbach A, Bourantas CV, Serruys PW, Wijns W. The year in cardiology: coronary interventions: The year in cardiology 2019. European Heart Journal.2020:41[3): 394–405. https://doi.org/10.1093/eurheartj/ehz947
- Gonçalves Brandão SM. Rezende PC, Brunner-La Rocca HP, et al. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Eff Resour Alloc. 2018 ;16[ 55 ):1-14
doi: 10.1186/s12962-018-0158-z